Recombinant CD40L treatment protects allogeneic murine bone marrow transplant recipients from death caused by herpes simplex virus-1 infection

Blood

Volumn 92, Issue 11, 1998, Pages 4472-4478

  Beland, Janice L ^b   Adler, Heiko ^b   Del Pan, Nadia C ^b   Kozlow, Wende ^b   Sung, Janice ^b   Fanslow, William ^b   Rimm, Ilonna J ^a  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; INTERLEUKIN 5; LIGAND; LIPOPOLYSACCHARIDE; VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENCEPHALITIS; VIRUS INFECTION;

EID: 0032400848     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.11.4472     Document Type: Article

References (37)

1. Meyers JD: Infection in bone marrow transplantation recipients. Am J Med 81:27, 1986
2. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor recipients. Blood 86:3979, 1995
3. Storek J, Saxon A: Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 9:395, 1992
4. Villers D, Milpied N, Gaschet J, Hallet M-M, Bonneville M, Vié H: Alteration of the T cell repertoire after bone marrow transplantation. Bone Marrow Transplant 13:19, 1994
5. Xenocostas A, Osmond DG, Lapp WS: The effect of the graft-versus-host reaction on B lymphocyte production in bone marrow of mice. Transplantation 51:1089, 1991
6. Wall DA, Hamberg SD, Reynolds DS, Burakoff SJ, Abbas AK, Ferrara JLM: Immunodeficiency in graft-versus-host disease. J Immunol 140:2970, 1988
7. Kagan JM, Champlin RE, Saxon A: B-cell dysfunction following human bone marrow transplantation: Functional-phenotypic dissociation in the early posttransplant period. Blood 74:777, 1989
8. Hollander GA, Widmer B, Burakoff SJ: Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol 152:1609, 1994
9. Garvy BA, Elia JM, Hamilton BL, Riley RL: Suppression of B-cell development as a result of selective expansion of donor T cells during the minor H antigen graft-versus-host reaction. Blood 82:2758, 1993
10. Grundy JE, Shanley JD, Shearer GM: Augmentation of graft-versus-host reaction by cytomegalovirus infection resulting in interstitial pneumonitis. Transplantation 39:548, 1985
11. Levy RB, Jones M, Cray C: HSV-1 enhances GvHR-associated parent anti-Fl alloreactivity in vivo and in vitro. Cell Immunol 129:1, 1990
12. Shanley JD, Via CS, Sharrow SO, Shearer GM: Interstitial pneumonitis during murine cytomegalovirus infection and graft-versus-host reaction. Transplantation 44:658, 1987
13. Funakoshi S, Taub DD, Anver MR, Razluddin A, Asai O, Reddy V, Rager H, Fanslow WC, Longo DL, Murphy WJ: Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice. J Clin Invest 99:484, 1997
14. Noelle RJ: CD40 and its ligand in host defense. Immunity 4:415, 1996
15. Foy TM, Aruffo A, Bajorath J, Bulman JE, Noelle RJ: Immune regulation by CD40 and its ligand gp39. Annul Rev Immunol 14:519, 1996
16. Kitamura D, Roes J, Kühn R, Rajewsky K: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423, 1991
17. Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm IJ: Suppression of Herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide sythase(iNOS, NOS2). J Exp Med 185:1533, 1997
18. Mitchell BM, Stevens JG: Neuroinvasive properties of herpes simplex virus type I glycoprotein variants are controlled by the immune response. J Immunol 156:246, 1996
19. Stevens JG: HSV-1 neuroinvasiveness. Intervirology 35:152, 1993
20. Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ: Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6:267, 1994
21. Nguyen L, Knipe DM, Finberg RW; Mechanism of virus-induced Ig subclass shifts. J Immunol 152:478, 1994
22. McKnight AJ, Shea CM, Wiens GR, Rimm IJ, Abbas AK: Differentiation of Vβ8.2+ CD4+ T cells induced by a superantigen: Roles of antigen-presenting cells and cytokines. Immunology 81:513, 1994
23. Kohl S, Strynadka NCJ, Hodges RS, Pereira L: Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B. J Clin Invest 86:273, 1990
24. Coutelier J-P, van der Logt JTM, Heessen FWA, Vink A, van Snick J: Virally induced modulation of murine IgG antibody subclasses. J Expl Med 168:2373, 1988
25. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787, 1996
26. De Wit D, Van Mechelen M, Zanin C, Doutrelepont J-M, Velu T, Gerard C, Abramowicz D, Scheerlinck J-P, De Baetselier P, Urbain J, Leo O, Goldman M, Moser M: Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol 150:361, 1993
27. Allen RD, Staley TA, Sidman CL: Differential cytokine expression in acute and chronic muring graft-versus-host disease. Eur J Immunol 23:333, 1993
28. Arrunategui-Correa V, Dutt J, Foster CS: The role of B lymphocytes in experimental Herpes Simplex retinitis. Scand J Immunol 40:299, 1994
29. 28a. Beland JL, Sobel RA, Adler H, Del-Pan NC, Rimm IJ: B cell-deficient mice have increased susceptibility to HSV-1 encephalomyelitis and mortality. J Neuroimmunol (in press)
30. Cray C, Levy RB: The presence of infectious virus but not conventional antigen can exacerbate graft-versus-host reactions. Scand J Immunol 32:177, 1990
31. Via CS, Shanley JD, Weatherly BR, Lang P, Shearer GM: Altered threshold for the induction of graft-versus-host immunodeficiency following murine cytomegalovirus infection. Transplantation 46:298, 1988
32. Shanley JD, Korngold R. Forman SJ: The effect of graft-versus-host disease in response to minor histocompatibility antigens on acute murine cytomegalovirus infection. Transplantation 56:487, 1993
33. Storek J, Witherspoon RP, Luthy D, Storb R: Low IgG production by mononuclear cells from marrow transplant survivors and from normal neonates is due to a defect of B cells. Bone Marrow Transplant 15:679, 1995
34. Xenocostas A, Lapp WS, Osmond DG: Suppression of B lymphocyte genesis in the bone marrow by systemic graft-versus-host reactions. Transplantation 43:549, 1987
35. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 158:29, 1997
36. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ: Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J Clin Invest 94:1333, 1994
37. Reed LJ, Muench H: A simple method of estimating fifty per cent endpoints. Am J Hygiene 27:493, 1938